TELETRADER News
12/13/2022, 5:45 PM
(Source: TeleTrader)
Moderna soars 22% on cancer vaccine breakthrough
The shares of Moderna Inc. skyrocketed more than 22% on Tuesday following the news that its collaboration with Merck on developing a cancer vaccine delivered encouraging results.
The companies said earlier today that Moderna's cancer vaccine decreased the risks of relapse or death by 44% when combined with Merck's Keytruda immunotherapy.
At 11:43 am ET, Moderna's stock jumped 22.62% to $202.33 apiece, rebounding to its highest levels since January.